| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Stock Option (right to buy) | 126K | Dec 13, 2024 | Direct | ||
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | 124K | Feb 5, 2025 | Direct | ||
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Incentive Stock Option (right to buy) | 5.37K | Feb 5, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PVLA | PALVELLA THERAPEUTICS, INC. | Feb 5, 2025 | 2 | $0 | 4/A | Feb 10, 2025 | Chief Scientific Officer |
| PVLA | PALVELLA THERAPEUTICS, INC. | Dec 13, 2024 | 1 | $0 | 4 | Dec 17, 2024 | Chief Scientific Officer |
| PVLA | PALVELLA THERAPEUTICS, INC. | Dec 13, 2024 | 0 | $0 | 3 | Dec 16, 2024 | Chief Scientific Officer |